Video
Preventive pharmacological therapy is beneficial in patients with recurrent stones when using 24-hour urine testing
Author(s):
“The take home message would be that in patients with prior history of kidney stone episodes…receiving 24-hour urine testing prior to starting pharmacologic preventive therapy is associated with a lower probability of a subsequent stone-related event,” says Ryan Hsi, MD, FACS.
Video Player is loading.
In this video, Ryan Hsi, MD, FACS, discusses the recent Urology study, “Comparison of Selective Versus Empiric Pharmacologic Preventive Therapy of Kidney Stone Recurrence with High-Risk Features,” for which he served as first author. Hsi is an associate professor of urology at Vanderbilt University Medical Center in Nashville, Tennessee.
Related Videos
Eugene Cone, MD, outlines potential impact of Expanded Access Program for rBCG
Investigators evaluate tamsulosin use in pediatric patients
Ruchika Talwar, MD, on how urologists can get involved in advocacy
Chad Ellimoottil, MD, on how urologists should approach telehealth in changing policy environment
How recombinant BCG could ease strain of supply issues
Katherine Chan, MD, on viral vs non-viral vectors in bladder cancer
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
Pain management disparities in kidney stones point to need for guidelines, experts say
John Taylor, III, MD, on novel options in NMIBC
FDA testosterone labeling changes: How will they affect prescribing?
Related Content
